0001213900-21-034018.txt : 20210624
0001213900-21-034018.hdr.sgml : 20210624
20210624180053
ACCESSION NUMBER: 0001213900-21-034018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210622
FILED AS OF DATE: 20210624
DATE AS OF CHANGE: 20210624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tesi Raymond Joseph
CENTRAL INDEX KEY: 0001767280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 211043998
MAIL ADDRESS:
STREET 1: 476 MASSACHUSETTS AVE, UNIT 2
CITY: BOSTON
STATE: MA
ZIP: 02118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2021-06-22
0
0001711754
Inmune Bio, Inc.
INMB
0001767280
Tesi Raymond Joseph
C/O INMUNE BIO INC.,
1200 PROSPECT STREET, SUITE 525
LA JOLLA,
CA
92037
1
1
1
0
President & CEO
Option
17.49
2021-06-22
4
A
0
70663
0
A
2031-06-22
Common Stock
70663
70663
D
Each Option represents a right to receive one share of common stock of INmune Bio, Inc.
Options granted pursuant to 2021 Stock Incentive Plan. Twenty-five percent of the Option will vest 12 months from the date of grant and thereafter the remaining unvested Option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the Option is 100% vested which shall occur on the four-year anniversary of the date of grant.
/s/ Raymond J. Tesi
2021-06-24